Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Assets (2022 - 2025)

Historic Return on Assets for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 0.52%.

  • Centessa Pharmaceuticals' Return on Assets fell 2000.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of 0.5% for FY2024, which is 1300.0% down from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Return on Assets of 0.52% as of Q3 2025, which was down 2000.0% from 0.45% recorded in Q2 2025.
  • Centessa Pharmaceuticals' Return on Assets' 5-year high stood at 0.32% during Q3 2024, with a 5-year trough of 0.52% in Q3 2025.
  • Its 4-year average for Return on Assets is 0.43%, with a median of 0.42% in 2023.
  • Per our database at Business Quant, Centessa Pharmaceuticals' Return on Assets skyrocketed by 1000bps in 2024 and then plummeted by -2000bps in 2025.
  • Centessa Pharmaceuticals' Return on Assets (Quarter) stood at 0.47% in 2022, then increased by 12bps to 0.41% in 2023, then rose by 3bps to 0.4% in 2024, then decreased by -30bps to 0.52% in 2025.
  • Its Return on Assets was 0.52% in Q3 2025, compared to 0.45% in Q2 2025 and 0.41% in Q1 2025.